W. van den Bijllaardt, I.T. Overdevest, A.G. Buiting, J.J. Verweij

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Vaccines for the elderly

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Detection of Fusobacterium necrophorum subsp

A. Bergman, D. Heimer, N. Kondori, H. Enroth

Benchmarking inappropriate empirical antibiotic treatment

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

A.G. Koek, S.M. Bruisten, M. Dierdorp, A.P. van Dam, K. Templeton

J. Ambrosioni, A. Mamin, A. Hadengue, M. Bernimoulin, K. Samii, C

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

O. Clerc, G. Greub Clinical Microbiology and Infection

Recurrent late-onset sepsis in the neonatal intensive care unit: incidence, clinical characteristics and risk factors M.-H. Tsai, S.-M. Chu, C.-W. Lee,

R. Cantón Clinical Microbiology and Infection

Detection of diarrhoea-causing protozoa in general practice patients in The Netherlands by multiplex real-time PCR R. ten Hove, T. Schuurman, M. Kooistra,

Louis Pasteur, from crystals of life to vaccination

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Comparison of microscopy, real-time PCR and a rapid immunoassay for the detection of Giardia lamblia in human stool specimens T. Schuurman, P. Lankamp,

Legionella spp. in UK composts—a potential public health issue?

J. Cairo, R. Hachem, G. Rangaraj, B. Granwehr, I. Raad

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul

A family cluster of giardiasis with variable treatment responses: refractory giardiasis in a family after a trip to India A. Requena-Méndez, P. Goñi,

Vector control: a cornerstone in the malaria elimination campaign

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

Does it make sense to detect Streptococcus pyogenes during tonsillitis in Europe to prevent acute rheumatic fever? S. Edouard, A. Michel-Lepage, D. Raoult

R. Karakus, K. Caglar, C. Aybay Clinical Microbiology and Infection

C. Fabrizio, A. Procopio Clinical Microbiology and Infection

Z. Wang, Z. Cui, Y. Li, T. Hou, X. Liu, Y. Xi, Y. Liu, H. Li, Q. He

Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.

S. Imbert, J.-Y. Brossas, M. Palous, I. Joly, I. Meyer, A. Fekkar

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

T.M. File Clinical Microbiology and Infection

Systematic review of antibiotic consumption in acute care hospitals

Antibacterial drug discovery in the 21st century

The role of antimalarial treatment in the elimination of malaria

Abstracts cont. Clinical Microbiology and Infection

Benchmarking inappropriate empirical antibiotic treatment

Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial

Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China Y. Luo, Y. Wang, L. Ye, J. Yang Clinical.

A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures A. Makristathis, S. Riss, A.M. Hirschl

Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci H.L. DuPont, Z.-D. Jiang Clinical Microbiology.

Current experience in treating invasive zygomycosis with posaconazole

A.P. Underwood, J. Green Clinical Microbiology and Infection

Vaccines for the elderly

Clinical infection services—the Leiden experience

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

O. Clerc, G. Greub Clinical Microbiology and Infection

Nebulized hypertonic saline treatment in hospitalized children with moderate to severe viral bronchiolitis Z. Luo, Z. Fu, E. Liu, X. Xu, X. Fu, D. Peng,

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Diarrhoea in general practice: when should a Clostridium difficile infection be considered? Results of a nested case-control study M.P.M. Hensgens, O.M.

Z. Erjavec, H. Kluin-Nelemans, P.E. Verweij

A. van Samkar, M. C. Brouwer, Y. Pannekoek, A. van der Ende, D

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Modelling during an emergency: the 2009 H1N1 influenza pandemic

J.L. Balcázar Clinical Microbiology and Infection

Three years experience of real-time PCR for the diagnosis of Q fever

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Localized Mycobacterium avium complex infection in a patient on HAART

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients D. He, S. Guo, P. Zhu, S. Tao, M. Li,

Presentation transcript:

Rapid clearance of Giardia lamblia DNA from the gut after successful treatment W. van den Bijllaardt, I.T. Overdevest, A.G. Buiting, J.J. Verweij Clinical Microbiology and Infection Volume 20, Issue 11, Pages O972-O974 (November 2014) DOI: 10.1111/1469-0691.12626 Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Flow-chart of inclusion, number of follow-up samples received and test results of this study. Clinical Microbiology and Infection 2014 20, O972-O974DOI: (10.1111/1469-0691.12626) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Giardia lamblia DNA load before (Initial), immediately after (FU1) and 1 week after (FU2) treatment. Separate lines represent samples of individual patients, dotted lines with X marks (n = 10) represent patients who only returned FU1. 1/CT = 1/cycle threshold, 1/CT <0.020 is considered negative. Clinical Microbiology and Infection 2014 20, O972-O974DOI: (10.1111/1469-0691.12626) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions